期刊文献+

AT1R基因A1166C多态性与非酒精性脂肪性肝炎关系的研究 被引量:2

Correlation of AT1R-A1166C genetic polymorphisms with NASH
在线阅读 下载PDF
导出
摘要 目的:研究血管紧张素1型受体(angiotensin type 1 receptor,AT1R)基因A1166C多态性与日本高知地区非酒精性脂肪性肝炎(NASH)易感性的相关性,从基因学角度探讨NASH的发生发展机制,为NASH的预防、诊断和治疗提供一定的理论依据。方法:应用聚合酶链反应-限制性片段长度多态性(PCR-PFLP)方法对日本高知地区96例NASH患者和150例正常人AT1R-A1166C基因多态性进行分析。结果:NASH病例组A等位基因频率与正常对照组相比差异无统计学意义(P>0.05)。NASH病例组AA基因型频率与正常对照组相比差异无统计学意义(P>0.05)。结论:AT1R-A1166C基因多态性与NASH的发生发展尚未显示相关。 Objective:To investigate the relationship between genetic polymorphism in angiotensin Ⅱtype 1 receptor(AT1R) and NASH in Japanese Kochi area to study the mechanism of NASH in gene and supply the foundations for prevention,diagnosis and therapy.Methods:In 96 patients with biopsy-proven NASH and150 healthy volunteers,the genetic polymorphisms in angiotensin Ⅱtype 1 receptor(AT1R-A1166C) were determined by polymerase chain reaction(PCR) and restriction fragment length polymorphism(RFLP).Results:The A-allele and AA-genotype of the AT1R-A1166C polymorphism showed no significantly difference in genotype distribution in NASH patients than in healthy volunteers(P0.05).Conclusion:The polymorphism of AT1R-A1166C of angiotensin Ⅱtype 1 receptor has no correlation with NASH.
出处 《黑龙江医药科学》 2010年第6期12-13,共2页 Heilongjiang Medicine and Pharmacy
基金 黑龙江省研究生创新项目(NO.YJSCX2009-111HLJ) 佳木斯大学科学技术研究项目(NO.S2009-069)
关键词 血管紧张素Ⅱ1型受体 非酒精性脂肪性肝炎 单核苷酸多态性 血管紧张素Ⅱ angiotensin Ⅱtype 1 receptor(AT1R) nonalcoholic steatohepatitis(NASH) SNPs angotensinⅡ
作者简介 梁衍锋(1980~)女,黑龙江佳木斯人,硕士,讲师。 通讯简介:王淑秋(1957-)女,黑龙江佳木斯人,硕士,教授。
  • 相关文献

参考文献6

  • 1Yoshiike N,Lwin H.Epidemiological aspects of obesity and NASH/NAFLD in Japan[J].Hepatol Res,2005,33(2):77-82.
  • 2姚华,李玉华,朱滨,吴晓华,陆胜德.非酒精性脂肪性肝病相关基因的单核苷酸多态性研究[J].癌变.畸变.突变,2006,18(3):230-233. 被引量:4
  • 3Lieberman J,Sastre A.Angiotensin converting enzyme activity in postmortery human tissues[J].Lablnvest,01983,48(6),711.
  • 4Kim S,Sohani-Bejnood M,Quignard-Boulange A,et al.The adipose Renin-Angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal Renin-Angiotensin system[J].J Biomed Biotechnol,2006,2006(5):27012.
  • 5薛建波,林懋惺,杨丽.血管紧张素转换酶及血管紧张素Ⅱ1型受体基因多态性与乙型肝炎肝硬化的关系[J].临床荟萃,2009,24(8):661-665. 被引量:3
  • 6Sookoian S,Castano G,Garcia SI,et al.A1166C angiotenain Ⅱ type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension[J].Am J Gastroenterol,2005,100(3),636-642.

二级参考文献30

  • 1高纯,顾国浩,夏正.汉族人群血管紧张素转换酶基因插入/缺失(I/D)的遗传多态性(英文)[J].中国临床康复,2006,10(44):188-190. 被引量:4
  • 2曾文,吴文成,王彦,傅淑霞.肾实质性高血压患者血管紧张素转换酶基因多态性与血管紧张素转换酶活性的研究[J].临床荟萃,2007,22(1):13-16. 被引量:1
  • 3Morrison CD, Papp AC, Hejmanowski AQ, et al. Increased D allele frequency of the angiotensin-eonverting enzyme gene in pulmonary fibrosis[J]. Hum Pathol,2001,32(5) :521-528.
  • 4Pinzani M,Gentilini P. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis[J]. Semin Liver Dis, 1999,19(4) : 397-410.
  • 5Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels[J]. J Clin Invest, 1990,86(4) : 1343-1346.
  • 6Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels[J]. Am J Hum Genet,1992,51(1) :197-205.
  • 7Ueda S,Meredith PA,Morton JJ,et al. ACE(I/D) genotype as apredietor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans[J]. Circulation, 1998,98(20):2148-2153.
  • 8Fabris C, Toniutto P, Bitetto D, et al. Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation[J]. J Gastroenterol, 2007,42 (7) : 543-549.
  • 9Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin Ⅱ type 1 receptor gene polymorphisms in human essential hypertension[J]. Hypertension, 1994,24(1) : 63-69.
  • 10Yoshiji H, Yoshii J, Ikenaka Y, et al. Inhibition of reninangiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats[J]. J Hepatol, 2002,37(1) :22-30.

共引文献4

同被引文献42

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部